MedPath

Integrated Coronary Multicenter Imaging Registry - Extended

Conditions
Coronary Artery Disease
Interventions
Other: OCT, coronary angiography, FFR
Registration Number
NCT04153903
Lead Sponsor
Yonsei University
Brief Summary

The coronary images of invasive angiography and optical coherence tomography (or Coronary CT angiography) with FFR(Fractional Flow Reserve) values of the intermediate lesions (50-70% stenosis) will be prospectively registered.

Detailed Description

Not available

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
200
Inclusion Criteria
  1. Patients who underwent coronary CT angiography because of chest pain
  2. Patients who need OCT or FFR evaluation because of intermediate lesions according to invasive angiography (diameter stenosis of 50-70%)
  3. Age: 20-80 yrs
  4. Patients who consent and fully understand the protocol
  5. Patients who consent the clinical follow-up
  6. Patients who can be followed-up
Exclusion Criteria
  1. Patients who had contrast allergy
  2. Patients who had unstable blood pressure needing the vasopressors
  3. Patients who had severe left ventricular function (left ventricular ejection fraction<30%)
  4. Chronic kidney disease who had Cr level of greater than 2.0 mg/dl
  5. Patients whose expected survival is less than 12 months
  6. Patients who had a severe valvular disease

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients with intermediate lesionsOCT, coronary angiography, FFRImaging cohort will be performed invasive angiography and optical coherence tomography (or Coronary CT angiography) with FFR(Fractional Flow Reserve) values of the intermediate lesions (50-70% stenosis)
Primary Outcome Measures
NameTimeMethod
Comparison of computed FFR derived by coronary images and real FFR valuesat registration

FFR values computed by OCT/CT/invasive coronary angiography will be compared by real invasive FFR values

Secondary Outcome Measures
NameTimeMethod
Adverse event (Death, acute myocardial infarction)2 years after registration

Death and occurrence of myocardial infarction during follow-up period will be assessed.

Trial Locations

Locations (1)

Division of Cardiology, Cardiovascular Hospital, Yonsei University

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath